Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Blatt Gregory R, Director. Director active across 1 company, notably Vaxxinity, Inc.. Cumulatively, 2 reports have been logged. Activity tracked since 16 November 2021. The latest transaction was disclosed on 16 November 2021 (J). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Gregory R. Blatt is a Director at Vaxxinity, Inc. In this role, he participates in the governance of the company and the development of its strategy. Vaxxinity, Inc. is a biopharmaceutical company focused on developing innovative vaccine solutions. Blatt leverages his industry experience to guide the company in its research and development initiatives, thereby contributing to public health improvements.